Journal of Clinical Pediatrics >

2022 , Vol. 40 >Issue 7: 500 - 504

DOI: https://doi.org/10.12372/jcp.2022.21e1680

Cardiovascular Disease

Changes and significance of dendritic cell subsets in children with Kawasaki disease

  • Nana WANG ,
  • Lijun MENG ,
  • Qianwen ZHANG ,
  • Fan ZHANG ,
  • Miao HOU ,
  • Ye CHEN ,
  • Bo WANG ,
  • Wenhua YAN ,
  • Haitao LYU ,
  • Ling SUN ,
  • Jie HUANG
Expand
  • 1. Department of Cardiology,Children’s Hospital of Soochow University, Suzhou 215025, Jiangsu, China
    2. Department of Hematology,Children’s Hospital of Soochow University, Suzhou 215025, Jiangsu, China
    3. Department of Respiratory Disease, Children’s Hospital of Soochow University, Suzhou 215025, Jiangsu, China

Received date: 2021-12-06

  Online published: 2022-07-08

Fold

Abstract

Objective To investigate the changes of dendritic cell (DC) subsets in children with acute Kawasaki disease (KD) and their significance. Methods The clinical data of children with initial acute KD from December 2020 to May 2021 were retrospectively analyzed. Blood samples of KD children were taken before and after intravenous immunoglobulin (IVIG) treatment. Flow cytometry was used to detect the number and proportion of DC subgroup plasmacytoid dendritic cells (pDC) and CD1c+ myeloid dendritic cells (mDC) in peripheral blood as well as the expression levels of human leucocyte antigen-DR (HLA-DR), CD86 and CD40 proteins. Children who underwent physical examination at the same period were selected as the control group. Results There were 32 children (19 boys and 13 girls) in the KD group, and the median age was 37.0 (22.3-58.5) months. In the control group, there were 23 children (14 boys and 9 girls) and the median age was 52.0 (30.0-65.0) months. The proportion of pDC and CD1c+mDC in peripheral blood DCs before and after IVIG treatment in KD group was lower than that in control group, and the proportion of CD1c+mDC in peripheral blood DCs after treatment was higher than that before treatment. The number of pDC and CD1c+mDC in pre-treatment group was lower than that in control group and post-treatment group, and the differences were statistically significant (P<0.05). The expression levels of CD86 and CD40 on pDC surface and the expression levels of HLA-DR and CD86 on CD1c+mDC surface were lower than those in control group and post-treatment group, with statistical significance (P<0.05). The number of pDC and CD1c+mDC in KD children in acute stage was significantly negatively correlated with c-reactive protein and neutrophil to lymphocyte ratio (P<0.05). The number of CD1c+mDC was also negatively correlated with ESR (P<0.05). Conclusions The number of pDC and CD1c+mDC in peripheral blood circulation of KD children was insufficient and their function was impaired. Circulating pDC and CD1c+mDC may be involved in the immunological pathogenesis of KD.

Key words： Kawasaki disease; dendritic cell; antigen-presenting molecule; costimulatory molecule

Cite this article

Nana WANG , Lijun MENG , Qianwen ZHANG , Fan ZHANG , Miao HOU , Ye CHEN , Bo WANG , Wenhua YAN , Haitao LYU , Ling SUN , Jie HUANG . Changes and significance of dendritic cell subsets in children with Kawasaki disease[J]. Journal of Clinical Pediatrics, 2022 , 40(7) : 500 -504 . DOI: 10.12372/jcp.2022.21e1680

References

[1] Fukazawa R, Kobayashi J, Ayusawa M, et al. JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease[J]. Circ J, 2020, 84(8): 1348-1407.
[2] Kainth R, Shah P. Kawasaki disease: origins and evolution[J]. Arch Dis Child, 2021, 106(4): 413-414.
[3] Zhou C, Zhao Y, Wang X, et al. Laboratory parameters between multisystem inflammatory syndrome in children and Kawasaki disease[J]. Pediatr Pulmonol, 2021, 56(12): 3688-3698.
[4] Schulte D, Yilmaz A, Shimada K, et al. Involvement of innate and adaptive immunity in a murine model of coronary arteritis mimicking Kawasaki disease[J]. J Immunol, 2009, 183(8): 5311-5318.
[5] Yilmaz A, Rowley A, Schulte DJ, et al. Activated myeloid dendritic cells accumulate and co-localize with CD3+ T cells in coronary artery lesions in patients with Kawasaki disease[J]. Exp Mol Pathol, 2007, 83(1): 93-103.
[6] Eisenbarth SC. Dendritic cell subsets in T cell programming: location dictates function[J]. Nat Rev Immunol, 2019, 19(2): 89-103.
[7] Wculek SK, Cueto FJ, Mujal AM, et al. Dendritic cells in cancer immunology and immunotherapy[J]. Nat Rev Immunol, 2020, 20(1): 7-24.
[8] Wu M, Gao L, He M, et al. Plasmacytoid dendritic cell deficiency in neonates enhances allergic airway inflammation via reduced production of IFN-α[J]. Cell Mol Immunol, 2020, 17(5): 519-532.
[9] McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association[J]. Circulation, 2017, 135(17): e927-e999.
[10] Reizis B. Plasmacytoid dendritic cells: development, regulation, and function[J]. Immunity, 2019, 50(1): 37-50.
[11] Chang A, Islam S. Kawasaki disease and vasculitis associated with immunization[J]. Pediatr Int, 2018, 60(7): 613-617.
[12] Burns JC, Song Y, Bujold M, et al. Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin[J]. Clin Exp Immunol, 2013, 174(3): 337-344.
[13] Kim HY, Lee HG, Kim DS. Apoptosis of peripheral blood mononuclear cells in Kawasaki disease[J]. J Rheumatol, 2000, 27(3): 801-806.
[14] Dress RJ, Wong AY, Ginhoux F. Homeostatic control of dendritic cell numbers and differentiation[J]. Immunol Cell Biol, 2018, 96(5): 463-476.
[15] Hwang SY, Shin TG, Jo IJ, et al. Neutrophil-to-lymphocyte ratio as a prognostic marker in critically-ill septic patients[J]. Am J Emerg Med, 2017, 35(2): 234-239.
Options
Outlines

/

〈 〉

Website Copyright © 2018 Journal of Clinical Pediatrics.
Tel: 021-25076489　E-mail: jcperke@126.com
Powered by Beijing Magtech Co. Ltd